End-of-day quote
Johannesburg S.E.
23:00:00 29/04/2024 BST
|
5-day change
|
1st Jan Change
|
224.3
ZAR
|
+0.52%
|
|
+3.48%
|
+10.21%
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
45,802
|
65,412
|
73,836
|
62,047
|
81,701
|
99,788
|
-
|
-
|
Enterprise Value (EV)
1 |
84,786
|
100,640
|
90,136
|
78,111
|
100,071
|
121,692
|
118,867
|
113,904
|
P/E ratio
|
6.38
x
|
14
x
|
15.4
x
|
9.71
x
|
15.6
x
|
17.1
x
|
11.9
x
|
10.5
x
|
Yield
|
3.14%
|
-
|
1.62%
|
2.34%
|
1.86%
|
1.56%
|
1.9%
|
2.12%
|
Capitalization / Revenue
|
1.18
x
|
1.69
x
|
1.96
x
|
1.61
x
|
2.01
x
|
2.24
x
|
1.97
x
|
1.83
x
|
EV / Revenue
|
2.18
x
|
2.6
x
|
2.39
x
|
2.02
x
|
2.46
x
|
2.73
x
|
2.34
x
|
2.09
x
|
EV / EBITDA
|
7.83
x
|
9.18
x
|
9.06
x
|
7.09
x
|
9.02
x
|
10.9
x
|
8.5
x
|
7.39
x
|
EV / FCF
|
23.8
x
|
18.1
x
|
26.6
x
|
29.2
x
|
42.8
x
|
20.2
x
|
14.2
x
|
9.81
x
|
FCF Yield
|
4.2%
|
5.53%
|
3.77%
|
3.43%
|
2.34%
|
4.95%
|
7.02%
|
10.2%
|
Price to Book
|
0.83
x
|
0.95
x
|
1.13
x
|
0.89
x
|
0.95
x
|
1.11
x
|
1.04
x
|
0.98
x
|
Nbr of stocks (in thousands)
|
455,970
|
455,800
|
455,522
|
446,252
|
444,946
|
444,946
|
-
|
-
|
Reference price
2 |
100.4
|
143.5
|
162.1
|
139.0
|
183.6
|
224.3
|
224.3
|
224.3
|
Announcement Date
|
11/09/19
|
09/09/20
|
01/09/21
|
31/08/22
|
30/08/23
|
-
|
-
|
-
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
38,872
|
38,647
|
37,766
|
38,606
|
40,709
|
44,557
|
50,721
|
54,415
|
EBITDA
1 |
10,824
|
10,968
|
9,945
|
11,012
|
11,100
|
11,141
|
13,983
|
15,418
|
EBIT
1 |
5,528
|
7,060
|
7,072
|
8,671
|
7,822
|
9,020
|
11,912
|
13,254
|
Operating Margin
|
14.22%
|
18.27%
|
18.73%
|
22.46%
|
19.21%
|
20.24%
|
23.49%
|
24.36%
|
Earnings before Tax (EBT)
1 |
3,490
|
5,602
|
5,989
|
8,134
|
6,555
|
7,815
|
10,865
|
12,186
|
Net income
1 |
7,182
|
4,664
|
4,806
|
6,488
|
5,228
|
6,228
|
8,458
|
9,724
|
Net margin
|
18.48%
|
12.07%
|
12.73%
|
16.81%
|
12.84%
|
13.98%
|
16.68%
|
17.87%
|
EPS
2 |
15.74
|
10.22
|
10.53
|
14.32
|
11.77
|
13.13
|
18.85
|
21.44
|
Free Cash Flow
1 |
3,560
|
5,570
|
3,394
|
2,677
|
2,339
|
6,023
|
8,347
|
11,609
|
FCF margin
|
9.16%
|
14.41%
|
8.99%
|
6.93%
|
5.75%
|
13.52%
|
16.46%
|
21.33%
|
FCF Conversion (EBITDA)
|
32.89%
|
50.78%
|
34.13%
|
24.31%
|
21.07%
|
54.06%
|
59.69%
|
75.3%
|
FCF Conversion (Net income)
|
49.57%
|
119.43%
|
70.62%
|
41.26%
|
44.74%
|
96.72%
|
98.69%
|
119.39%
|
Dividend per Share
2 |
3.150
|
-
|
2.620
|
3.260
|
3.420
|
3.496
|
4.263
|
4.747
|
Announcement Date
|
11/09/19
|
09/09/20
|
01/09/21
|
31/08/22
|
30/08/23
|
-
|
-
|
-
|
Fiscal Period: Juni |
2020 S1
|
2021 S1
|
2022 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
18,417
|
-
|
19,225
|
-
|
23,873
|
EBITDA
1 |
5,260
|
-
|
5,296
|
-
|
6,407
|
EBIT
1 |
3,644
|
-
|
4,113
|
-
|
6,064
|
Operating Margin
|
19.79%
|
-
|
21.39%
|
-
|
25.4%
|
Earnings before Tax (EBT)
|
2,969
|
-
|
3,940
|
-
|
-
|
Net income
1 |
2,629
|
2,549
|
3,128
|
2,314
|
4,294
|
Net margin
|
14.27%
|
-
|
16.27%
|
-
|
17.99%
|
EPS
|
-
|
5.584
|
9.758
|
5.208
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
4.000
|
Announcement Date
|
05/03/20
|
11/03/21
|
31/08/22
|
15/01/24
|
-
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
38,984
|
35,228
|
16,300
|
16,064
|
18,370
|
21,904
|
19,079
|
14,116
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.602
x
|
3.212
x
|
1.639
x
|
1.459
x
|
1.655
x
|
1.966
x
|
1.364
x
|
0.9155
x
|
Free Cash Flow
1 |
3,560
|
5,570
|
3,394
|
2,677
|
2,339
|
6,023
|
8,347
|
11,609
|
ROE (net income / shareholders' equity)
|
12.4%
|
10.8%
|
8.87%
|
9.5%
|
6.65%
|
7.22%
|
9.17%
|
9.65%
|
ROA (Net income/ Total Assets)
|
5.06%
|
5.23%
|
4.92%
|
-
|
4.26%
|
4.99%
|
6.32%
|
-
|
Assets
1 |
141,956
|
89,124
|
97,621
|
-
|
122,830
|
124,754
|
133,845
|
-
|
Book Value Per Share
2 |
120.0
|
152.0
|
144.0
|
157.0
|
194.0
|
202.0
|
216.0
|
230.0
|
Cash Flow per Share
2 |
13.10
|
18.10
|
15.00
|
11.90
|
12.40
|
26.90
|
15.70
|
20.40
|
Capex
1 |
3,583
|
2,690
|
3,431
|
2,697
|
3,181
|
4,200
|
2,900
|
-
|
Capex / Sales
|
9.22%
|
6.96%
|
9.08%
|
6.99%
|
7.81%
|
9.43%
|
5.72%
|
-
|
Announcement Date
|
11/09/19
|
09/09/20
|
01/09/21
|
31/08/22
|
30/08/23
|
-
|
-
|
-
|
Last Close Price
224.3
ZAR Average target price
232
ZAR Spread / Average Target +3.47% Consensus |
1st Jan change
|
Capi.
|
---|
| +10.21% | 5.31B | | +19.27% | 43.18B | | +24.24% | 23.23B | | +15.11% | 14.6B | | +12.33% | 13.54B | | +38.36% | 11.5B | | -7.79% | 6.79B | | -0.05% | 6.79B | | -8.87% | 5.73B | | -2.27% | 4.81B |
Generic Pharmaceuticals
|